Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	TPR PHC3 SP3 RUNX2 BRCA1 ARID1A EP400 CLOCK NIPBL TCF7L1 MED12	1.90e-07	739	41	11	GO:0003682
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MED15 MED12L TPR IRAK1BP1 KMT2C ANK1 BRCA1 ARID1A NIPBL MED12 SUPT7L	1.52e-05	1160	41	11	GO:0030674
GeneOntologyMolecularFunction	transcription coregulator activity	MED15 MED12L KMT2C BRCA1 ARID1A NIPBL MED12 SUPT7L	1.58e-05	562	41	8	GO:0003712
GeneOntologyMolecularFunction	transcription coactivator activity	MED12L KMT2C BRCA1 ARID1A MED12 SUPT7L	3.34e-05	303	41	6	GO:0003713
GeneOntologyMolecularFunction	molecular adaptor activity	MED15 MED12L TPR IRAK1BP1 KMT2C ANK1 BRCA1 ARID1A NIPBL MED12 SUPT7L	6.44e-05	1356	41	11	GO:0060090
GeneOntologyMolecularFunction	transcription factor binding	NFYA MED12L BDP1 SP3 RUNX2 ARID1A CLOCK MED12	1.25e-04	753	41	8	GO:0008134
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	NFYA NFYC SP2 SP3 SP4 RUNX2 CLOCK RFX3 TCF7L1 MED12	1.61e-04	1244	41	10	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	NFYA NFYC SP2 SP3 SP4 RUNX2 CLOCK RFX3 TCF7L1 MED12	1.92e-04	1271	41	10	GO:0000987
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	NFYA NFYC SP2 SP3 SP4 RUNX2 CLOCK RFX3 TCF7L1 MED12	5.80e-04	1459	41	10	GO:0000977
GeneOntologyMolecularFunction	nuclear import signal receptor activity	KPNA4 KPNA3	7.63e-04	20	41	2	GO:0061608
GeneOntologyMolecularFunction	nuclear localization sequence binding	KPNA4 KPNA3	1.40e-03	27	41	2	GO:0008139
GeneOntologyMolecularFunction	beta-catenin binding	MED12L TCF7L1 MED12	1.91e-03	120	41	3	GO:0008013
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	NFYA NFYC SP2 SP3 SP4 RUNX2 CLOCK RFX3 TCF7L1	1.91e-03	1412	41	9	GO:0000981
GeneOntologyMolecularFunction	nucleocytoplasmic carrier activity	KPNA4 KPNA3	1.96e-03	32	41	2	GO:0140142
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	ARID1A EP400	2.62e-03	37	41	2	GO:0140658
GeneOntologyMolecularFunction	histone deacetylase binding	SP2 RUNX2 NIPBL	3.40e-03	147	41	3	GO:0042826
GeneOntologyMolecularFunction	signal sequence binding	KPNA4 KPNA3	4.92e-03	51	41	2	GO:0005048
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	NFYA MED15 NFYC MED12L KMT2C SP3 RUNX2 BRCA1 CLOCK RFX3 NIPBL TCF7L1 MED12	2.25e-06	1390	42	13	GO:0045944
GeneOntologyBiologicalProcess	protein-DNA complex organization	MED15 BDP1 TPR KMT2C BRCA1 ARID1A EP400 CLOCK NIPBL TCF7L1 SMC6	3.49e-06	999	42	11	GO:0071824
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	TPR SP2 PHC3 SP3 RUNX2 BRCA1 ARID1A CLOCK RFX3 NIPBL TCF7L1 SCAF4	1.48e-05	1399	42	12	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	TPR SP2 PHC3 SP3 RUNX2 BRCA1 ARID1A CLOCK RFX3 NIPBL TCF7L1 SCAF4	1.64e-05	1413	42	12	GO:1902679
GeneOntologyBiologicalProcess	embryonic eye morphogenesis	MFAP2 SP3 ARID1A	6.30e-05	38	42	3	GO:0048048
GeneOntologyBiologicalProcess	chromatin organization	TPR KMT2C BRCA1 ARID1A EP400 CLOCK NIPBL TCF7L1 SMC6	6.47e-05	896	42	9	GO:0006325
GeneOntologyBiologicalProcess	somatic stem cell population maintenance	MED15 NIPBL TCF7L1 MED12	6.83e-05	108	42	4	GO:0035019
GeneOntologyBiologicalProcess	embryonic organ morphogenesis	MFAP2 SP3 RUNX2 ARID1A NIPBL MED12	7.28e-05	351	42	6	GO:0048562
GeneOntologyBiologicalProcess	protein localization to nucleus	CIZ1 KPNA4 TPR BRCA1 SUPT7L KPNA3	8.63e-05	362	42	6	GO:0034504
GeneOntologyBiologicalProcess	stem cell population maintenance	MED15 ARID1A NIPBL TCF7L1 MED12	1.15e-04	237	42	5	GO:0019827
GeneOntologyBiologicalProcess	embryonic organ development	SP2 MFAP2 SP3 RUNX2 ARID1A NIPBL MED12	1.25e-04	561	42	7	GO:0048568
GeneOntologyBiologicalProcess	maintenance of cell number	MED15 ARID1A NIPBL TCF7L1 MED12	1.27e-04	242	42	5	GO:0098727
GeneOntologyBiologicalProcess	embryonic cranial skeleton morphogenesis	RUNX2 NIPBL MED12	1.62e-04	52	42	3	GO:0048701
GeneOntologyBiologicalProcess	regulation of type B pancreatic cell development	CLOCK RFX3	1.80e-04	10	42	2	GO:2000074
GeneOntologyBiologicalProcess	embryonic skeletal system development	SP3 RUNX2 NIPBL MED12	2.30e-04	148	42	4	GO:0048706
GeneOntologyBiologicalProcess	double-strand break repair	BRCA1 ARID1A EP400 NIPBL SMC6	4.90e-04	324	42	5	GO:0006302
GeneOntologyBiologicalProcess	cellular response to ionizing radiation	BRCA1 CLOCK NIPBL	4.98e-04	76	42	3	GO:0071479
GeneOntologyBiologicalProcess	nuclear receptor-mediated glucocorticoid signaling pathway	ARID1A CLOCK	5.40e-04	17	42	2	GO:0042921
GeneOntologyBiologicalProcess	double-strand break repair via homologous recombination	BRCA1 EP400 NIPBL SMC6	5.71e-04	188	42	4	GO:0000724
GeneOntologyBiologicalProcess	nuclear receptor-mediated corticosteroid signaling pathway	ARID1A CLOCK	6.07e-04	18	42	2	GO:0031958
GeneOntologyBiologicalProcess	recombinational repair	BRCA1 EP400 NIPBL SMC6	6.42e-04	194	42	4	GO:0000725
GeneOntologyBiologicalProcess	protein import into nucleus	KPNA4 TPR BRCA1 KPNA3	6.55e-04	195	42	4	GO:0006606
GeneOntologyBiologicalProcess	cranial skeletal system development	RUNX2 NIPBL MED12	6.67e-04	84	42	3	GO:1904888
GeneOntologyBiologicalProcess	chromatin remodeling	TPR KMT2C BRCA1 ARID1A EP400 CLOCK NIPBL	6.76e-04	741	42	7	GO:0006338
GeneOntologyBiologicalProcess	import into nucleus	KPNA4 TPR BRCA1 KPNA3	7.33e-04	201	42	4	GO:0051170
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	KPNA4 KPNA3	7.51e-04	20	42	2	GO:0006607
GeneOntologyBiologicalProcess	eye morphogenesis	MFAP2 SP3 ARID1A NIPBL	7.75e-04	204	42	4	GO:0048592
GeneOntologyBiologicalProcess	regulation of DNA metabolic process	CIZ1 BRCA1 ARID1A EP400 SUPT7L SMC6	9.25e-04	564	42	6	GO:0051052
GeneOntologyBiologicalProcess	nuclear transport	KPNA4 TPR SMG7 BRCA1 KPNA3	9.81e-04	378	42	5	GO:0051169
GeneOntologyBiologicalProcess	nucleocytoplasmic transport	KPNA4 TPR SMG7 BRCA1 KPNA3	9.81e-04	378	42	5	GO:0006913
GeneOntologyBiologicalProcess	DNA-templated transcription initiation	MED15 BDP1 ARID1A MED12	1.23e-03	231	42	4	GO:0006352
GeneOntologyBiologicalProcess	maintenance of protein location in nucleus	CIZ1 SUPT7L	1.28e-03	26	42	2	GO:0051457
GeneOntologyBiologicalProcess	regulation of DNA repair	BRCA1 ARID1A EP400 SUPT7L	1.29e-03	234	42	4	GO:0006282
GeneOntologyBiologicalProcess	protein localization to organelle	CIZ1 KPNA4 FSIP2 TPR BRCA1 NIPBL SUPT7L KPNA3	1.41e-03	1091	42	8	GO:0033365
GeneOntologyBiologicalProcess	embryonic skeletal system morphogenesis	RUNX2 NIPBL MED12	1.42e-03	109	42	3	GO:0048704
GeneOntologyBiologicalProcess	type B pancreatic cell development	CLOCK RFX3	1.59e-03	29	42	2	GO:0003323
GeneOntologyCellularComponent	nuclear protein-containing complex	NFYA KPNA4 MED15 NFYC MED12L TPR KMT2C PHC3 SMG7 BRCA1 ARID1A EP400 CLOCK NIPBL TCF7L1 MED12 KPNA3	2.50e-10	1377	41	17	GO:0140513
GeneOntologyCellularComponent	transcription regulator complex	NFYA MED15 NFYC BDP1 SP3 RUNX2 CLOCK RFX3 TCF7L1	1.82e-06	596	41	9	GO:0005667
GeneOntologyCellularComponent	chromatin	NFYA NFYC SP2 SP3 SP4 RUNX2 ARID1A EP400 CLOCK RFX3 NIPBL TCF7L1 SUPT7L	2.88e-06	1480	41	13	GO:0000785
GeneOntologyCellularComponent	CCAAT-binding factor complex	NFYA NFYC	5.60e-05	6	41	2	GO:0016602
GeneOntologyCellularComponent	NLS-dependent protein nuclear import complex	KPNA4 KPNA3	1.67e-04	10	41	2	GO:0042564
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	NFYA MED15 NFYC CLOCK TCF7L1	1.84e-04	272	41	5	GO:0090575
GeneOntologyCellularComponent	nucleocytoplasmic transport complex	KPNA4 KPNA3	2.45e-04	12	41	2	GO:0031074
GeneOntologyCellularComponent	nuclear pore	KPNA4 TPR KPNA3	1.02e-03	101	41	3	GO:0005643
GeneOntologyCellularComponent	mediator complex	MED12L MED12	2.39e-03	37	41	2	GO:0016592
GeneOntologyCellularComponent	transferase complex	KMT2C PHC3 BRCA1 EP400 MED12 SUPT7L SMC6	2.46e-03	963	41	7	GO:1990234
HumanPheno	Thin vermilion border	MED12L TPR ABCC9 CEP152 QRICH1 RUNX2 BRCA1 ARID1A NIPBL MED12	2.01e-07	433	17	10	HP:0000233
HumanPheno	Thin upper lip vermilion	MED12L TPR ABCC9 CEP152 QRICH1 BRCA1 ARID1A NIPBL MED12	3.48e-07	339	17	9	HP:0000219
HumanPheno	Thin lips	MED12L TPR ABCC9 CEP152 QRICH1 BRCA1 ARID1A NIPBL MED12	3.48e-07	339	17	9	HP:0000213
HumanPheno	Abnormality of upper lip vermillion	MED12L TPR ABCC9 CEP152 QRICH1 BRCA1 ARID1A NIPBL MED12	5.00e-06	464	17	9	HP:0011339
HumanPheno	Abnormal external nose morphology	MED12L TPR ABCC9 CEP152 QRICH1 RUNX2 BRCA1 ARID1A NIPBL MED12 SCAF4	2.58e-05	916	17	11	HP:0010938
HumanPheno	Abnormal upper lip morphology	MED12L TPR ABCC9 CEP152 QRICH1 RUNX2 BRCA1 ARID1A NIPBL MED12 SCAF4	5.01e-05	980	17	11	HP:0000177
HumanPheno	High palate	MED12L CEP152 QRICH1 RUNX2 ANK1 BRCA1 ARID1A NIPBL MED12 SCAF4	5.47e-05	794	17	10	HP:0000218
HumanPheno	Malrotation of colon	NIPBL MED12	6.27e-05	4	17	2	HP:0004785
HumanPheno	Abnormal lip morphology	MED12L TPR ABCC9 KMT2C CEP152 QRICH1 RUNX2 BRCA1 ARID1A NIPBL MED12 SCAF4	7.90e-05	1249	17	12	HP:0000159
HumanPheno	Abnormal lower lip morphology	MED12L ABCC9 KMT2C QRICH1 ARID1A MED12	8.59e-05	242	17	6	HP:0000178
HumanPheno	Supernumerary ribs	RUNX2 ANK1 NIPBL	9.61e-05	28	17	3	HP:0005815
HumanPheno	Aplasia/Hypoplasia of fingers	ABCC9 CEP152 RUNX2 BRCA1 ARID1A NIPBL MED12	9.66e-05	366	17	7	HP:0006265
HumanPheno	Supernumerary bones of the axial skeleton	RUNX2 ANK1 NIPBL	1.07e-04	29	17	3	HP:0009144
HumanPheno	Recurrent maladaptive behavior	CIZ1 MED12L TPR ABCC9 KMT2C CEP152 BRCA1 ARID1A NIPBL MED12 SCAF4 KPNA3	1.14e-04	1293	17	12	HP:5200241
HumanPheno	Prominent lips	ABCC9 KMT2C BRCA1 ARID1A MED12	1.16e-04	156	17	5	HP:0000184
HumanPheno	Abnormal nasal tip morphology	MED12L TPR ABCC9 QRICH1 ARID1A MED12 SCAF4	1.36e-04	386	17	7	HP:0000436
HumanPheno	Abnormality of the philtrum	MED12L TPR ABCC9 QRICH1 RUNX2 ARID1A NIPBL MED12 SCAF4	1.92e-04	726	17	9	HP:0000288
HumanPheno	Clinodactyly	TPR CEP152 QRICH1 RUNX2 BRCA1 ARID1A NIPBL MED12	2.38e-04	574	17	8	HP:0030084
HumanPheno	Short phalanx of finger	ABCC9 CEP152 RUNX2 ARID1A NIPBL MED12	3.15e-04	306	17	6	HP:0009803
HumanPheno	Radial deviation of finger	TPR CEP152 QRICH1 RUNX2 BRCA1 NIPBL MED12	3.46e-04	448	17	7	HP:0009466
HumanPheno	Abnormal palate morphology	MED12L KMT2C CEP152 QRICH1 RUNX2 ANK1 BRCA1 ARID1A NIPBL MED12 SCAF4	3.56e-04	1202	17	11	HP:0000174
HumanPheno	Finger clinodactyly	TPR CEP152 QRICH1 RUNX2 BRCA1 NIPBL MED12	3.66e-04	452	17	7	HP:0040019
HumanPheno	Radial deviation of the hand or of fingers of the hand	TPR CEP152 QRICH1 RUNX2 BRCA1 NIPBL MED12	3.86e-04	456	17	7	HP:0009485
HumanPheno	Narrow palate	MED12L RUNX2 BRCA1 NIPBL MED12	3.91e-04	202	17	5	HP:0000189
HumanPheno	Aplasia/Hypoplasia of the phalanges of the hand	ABCC9 CEP152 RUNX2 ARID1A NIPBL MED12	3.95e-04	319	17	6	HP:0009767
HumanPheno	Short finger	ABCC9 CEP152 RUNX2 ARID1A NIPBL MED12	4.37e-04	325	17	6	HP:0009381
HumanPheno	Abnormal morphology of the nasal alae	MED12L TPR ABCC9 QRICH1 BRCA1 ARID1A NIPBL MED12	5.04e-04	639	17	8	HP:0000429
HumanPheno	Abnormality of the frontal hairline	ABCC9 BRCA1 ARID1A NIPBL MED12	5.22e-04	215	17	5	HP:0000599
HumanPheno	Abnormal nasal bridge morphology	MED12L TPR ABCC9 CEP152 RUNX2 ANK1 BRCA1 ARID1A NIPBL MED12	5.24e-04	1029	17	10	HP:0000422
HumanPheno	Long eyelashes	ABCC9 BRCA1 ARID1A NIPBL	7.23e-04	129	17	4	HP:0000527
HumanPheno	Blepharophimosis	CEP152 ANK1 BRCA1 MED12	7.23e-04	129	17	4	HP:0000581
HumanPheno	Abnormal 5th finger morphology	TPR CEP152 QRICH1 RUNX2 BRCA1 ARID1A NIPBL	7.60e-04	509	17	7	HP:0004207
HumanPheno	Pes planus	MED12L TPR CEP152 BRCA1 MED12 SCAF4	8.15e-04	365	17	6	HP:0001763
HumanPheno	Aggressive behavior	MED12L KMT2C CEP152 ARID1A NIPBL MED12 SCAF4	8.26e-04	516	17	7	HP:0000718
HumanPheno	Abnormal aggressive, impulsive or violent behavior	MED12L KMT2C CEP152 ARID1A NIPBL MED12 SCAF4	8.26e-04	516	17	7	HP:0006919
HumanPheno	Thick lower lip vermilion	ABCC9 KMT2C ARID1A MED12	8.83e-04	136	17	4	HP:0000179
HumanPheno	Abnormal thorax morphology	MED12L ABCC9 KMT2C CEP152 RUNX2 ANK1 BRCA1 ARID1A NIPBL MED12 SCAF4	9.01e-04	1328	17	11	HP:0000765
HumanPheno	Limited elbow extension	ABCC9 NIPBL MED12	9.39e-04	60	17	3	HP:0001377
HumanPheno	Hypospadias	MED12L CEP152 BRCA1 ARID1A NIPBL MED12	9.68e-04	377	17	6	HP:0000047
HumanPheno	Deviation of finger	TPR CEP152 QRICH1 RUNX2 BRCA1 NIPBL MED12	1.05e-03	537	17	7	HP:0004097
HumanPheno	Aplasia/hypoplasia involving bones of the hand	ABCC9 CEP152 RUNX2 BRCA1 ARID1A NIPBL MED12	1.06e-03	538	17	7	HP:0005927
HumanPheno	Anal atresia	KMT2C BRCA1 MED12 SCAF4	1.07e-03	143	17	4	HP:0002023
HumanPheno	Curly eyelashes	ABCC9 NIPBL	1.07e-03	15	17	2	HP:0007665
HumanPheno	Low anterior hairline	ABCC9 BRCA1 ARID1A NIPBL	1.18e-03	147	17	4	HP:0000294
HumanPheno	Impairment in personality functioning	CIZ1 MED12L ABCC9 KMT2C CEP152 ARID1A NIPBL MED12 SCAF4 KPNA3	1.25e-03	1141	17	10	HP:0031466
HumanPheno	Displacement of the urethral meatus	MED12L CEP152 BRCA1 ARID1A NIPBL MED12	1.27e-03	397	17	6	HP:0100627
HumanPheno	Abnormal male urethral meatus morphology	MED12L CEP152 BRCA1 ARID1A NIPBL MED12	1.31e-03	399	17	6	HP:0032076
HumanPheno	Abnormal finger morphology	MED12L TPR ABCC9 KMT2C CEP152 QRICH1 RUNX2 BRCA1 ARID1A NIPBL MED12	1.32e-03	1385	17	11	HP:0001167
HumanPheno	Anteverted nares	MED12L TPR ABCC9 QRICH1 BRCA1 ARID1A NIPBL	1.34e-03	559	17	7	HP:0000463
HumanPheno	Upturned nose	MED12L TPR ABCC9 QRICH1 BRCA1 ARID1A NIPBL	1.34e-03	559	17	7	HP:0000427
HumanPheno	Thick eyebrow	ABCC9 KMT2C ARID1A NIPBL	1.41e-03	154	17	4	HP:0000574
HumanPheno	Deviation of the hand or of fingers of the hand	TPR CEP152 QRICH1 RUNX2 BRCA1 NIPBL MED12	1.41e-03	564	17	7	HP:0009484
HumanPheno	Abnormal eyelid morphology	MED12L ABCC9 KMT2C CEP152 QRICH1 ANK1 BRCA1 ARID1A NIPBL MED12 SCAF4	1.53e-03	1408	17	11	HP:0000492
HumanPheno	Aplasia/hypoplasia involving bones of the upper limbs	ABCC9 CEP152 RUNX2 BRCA1 ARID1A NIPBL MED12	1.54e-03	572	17	7	HP:0006496
HumanPheno	Broad nasal tip	TPR ABCC9 QRICH1 ARID1A	1.58e-03	159	17	4	HP:0000455
HumanPheno	Abnormal nostril morphology	MED12L TPR ABCC9 QRICH1 BRCA1 ARID1A NIPBL	1.58e-03	575	17	7	HP:0005288
HumanPheno	Aplasia involving bones of the extremities	TPR ABCC9 CEP152 RUNX2 BRCA1 ARID1A NIPBL MED12	1.63e-03	759	17	8	HP:0009825
HumanPheno	Aplasia/hypoplasia involving bones of the extremities	TPR ABCC9 CEP152 RUNX2 BRCA1 ARID1A NIPBL MED12	1.66e-03	761	17	8	HP:0045060
HumanPheno	Thick vermilion border	ABCC9 KMT2C BRCA1 ARID1A MED12	1.71e-03	279	17	5	HP:0012471
HumanPheno	Clinodactyly of the 5th finger	TPR CEP152 QRICH1 RUNX2 BRCA1 NIPBL	1.71e-03	420	17	6	HP:0004209
HumanPheno	Clinodactyly of hands	TPR CEP152 QRICH1 RUNX2 BRCA1 NIPBL	1.73e-03	421	17	6	HP:0001157
HumanPheno	Deviation of the 5th finger	TPR CEP152 QRICH1 RUNX2 BRCA1 NIPBL	1.73e-03	421	17	6	HP:0009179
MousePheno	embryonic lethality during organogenesis	SP2 BRCA1 ARID1A EP400 RFX3 NIPBL SLC20A1 TCF7L1 MED12 SMC6	2.92e-05	876	34	10	MP:0006207
MousePheno	embryonic lethality during organogenesis, complete penetrance	SP2 BRCA1 ARID1A EP400 NIPBL SLC20A1 TCF7L1 MED12 SMC6	3.19e-05	700	34	9	MP:0011098
MousePheno	delayed intramembranous bone ossification	SP3 RUNX2 NIPBL	4.13e-05	28	34	3	MP:0003420
MousePheno	postnatal growth retardation	ABCC9 KMT2C SP4 RUNX2 ANK1 BRCA1 RFX3 NIPBL SLC20A1	1.89e-04	881	34	9	MP:0001732
MousePheno	increased nucleated erythrocyte cell number	RUNX2 ANK1 SLC20A1	1.98e-04	47	34	3	MP:0009395
MousePheno	abnormal nucleated erythrocyte cell number	RUNX2 ANK1 SLC20A1	2.24e-04	49	34	3	MP:0012397
MousePheno	decreased birth body size	SP3 RUNX2 ANK1 RFX3 NIPBL	2.27e-04	232	34	5	MP:0009703
MousePheno	abnormal postnatal growth	ABCC9 KMT2C SP4 RUNX2 ANK1 BRCA1 RFX3 NIPBL SLC20A1	2.35e-04	907	34	9	MP:0001731
MousePheno	abnormal birth body size	SP3 RUNX2 ANK1 RFX3 NIPBL	2.50e-04	237	34	5	MP:0009701
MousePheno	abnormal thymus morphology	CIZ1 SP3 SP4 QRICH1 RUNX2 ANK1 BRCA1 CLOCK	2.55e-04	717	34	8	MP:0000703
MousePheno	schistocytosis	ANK1 SLC20A1	2.55e-04	10	34	2	MP:0000314
MousePheno	delayed endochondral bone ossification	SP3 RUNX2 NIPBL	3.00e-04	54	34	3	MP:0003419
MousePheno	abnormal intramembranous bone ossification	SP3 RUNX2 NIPBL	4.30e-04	61	34	3	MP:0008273
MousePheno	spherocytosis	ANK1 SLC20A1	4.40e-04	13	34	2	MP:0002812
MousePheno	liver hypoplasia	SP3 RUNX2 SLC20A1	4.51e-04	62	34	3	MP:0000600
Domain	Sp1_fam	SP2 SP3 SP4	1.26e-06	10	42	3	IPR030450
Domain	Mediator_Med12_catenin-bd	MED12L MED12	4.94e-06	2	42	2	IPR021989
Domain	Med12-PQL	MED12L MED12	4.94e-06	2	42	2	PF12144
Domain	Med12-LCEWAV	MED12L MED12	4.94e-06	2	42	2	PF12145
Domain	Mediator_Med12	MED12L MED12	4.94e-06	2	42	2	IPR019035
Domain	Med12	MED12L MED12	4.94e-06	2	42	2	SM01281
Domain	Med12	MED12L MED12	4.94e-06	2	42	2	PF09497
Domain	Mediator_Med12_LCEWAV	MED12L MED12	4.94e-06	2	42	2	IPR021990
Domain	Arm_3	KPNA4 KPNA3	1.03e-04	7	42	2	PF16186
Domain	Importing_su_alpha	KPNA4 KPNA3	1.03e-04	7	42	2	IPR024931
Domain	Arm_3	KPNA4 KPNA3	1.03e-04	7	42	2	IPR032413
Domain	IBB	KPNA4 KPNA3	1.03e-04	7	42	2	PF01749
Domain	-	KPNA4 ARID1A NIPBL MED12 KPNA3	1.35e-04	222	42	5	1.25.10.10
Domain	IBB	KPNA4 KPNA3	1.37e-04	8	42	2	PS51214
Domain	Importin-a_IBB	KPNA4 KPNA3	1.76e-04	9	42	2	IPR002652
Domain	ARM-like	KPNA4 ARID1A NIPBL MED12 KPNA3	3.34e-04	270	42	5	IPR011989
Domain	ARM-type_fold	KPNA4 USP34 ARID1A NIPBL KPNA3	9.38e-04	339	42	5	IPR016024
Domain	Arm	KPNA4 KPNA3	2.20e-03	31	42	2	PF00514
Domain	MYB_LIKE	BDP1 EP400	3.30e-03	38	42	2	PS50090
Domain	ARM	KPNA4 KPNA3	3.65e-03	40	42	2	SM00185
Domain	ARM_REPEAT	KPNA4 KPNA3	3.65e-03	40	42	2	PS50176
Domain	Armadillo	KPNA4 KPNA3	5.01e-03	47	42	2	IPR000225
Domain	SANT	BDP1 EP400	5.65e-03	50	42	2	SM00717
Domain	SANT/Myb	BDP1 EP400	6.10e-03	52	42	2	IPR001005
Domain	HMG_box	KMT2C TCF7L1	6.33e-03	53	42	2	PF00505
Domain	HMG	KMT2C TCF7L1	6.56e-03	54	42	2	SM00398
Pathway	BIOCARTA_TERC_PATHWAY	NFYA NFYC SP3	2.33e-07	6	33	3	MM1564
Pathway	BIOCARTA_TERC_PATHWAY	NFYA NFYC SP3	2.33e-07	6	33	3	M22047
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NFYA MED15 NFYC CLOCK MED12	7.43e-06	118	33	5	M27316
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	TPR PHC3 BRCA1 SMC6	2.99e-05	77	33	4	M27226
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	TPR PHC3 BRCA1 SMC6	4.21e-05	84	33	4	MM14929
Pathway	REACTOME_SUMOYLATION	TPR PHC3 SP3 BRCA1 SMC6	4.22e-05	169	33	5	MM14919
Pathway	REACTOME_SUMOYLATION	TPR PHC3 SP3 BRCA1 SMC6	7.19e-05	189	33	5	M27214
Pathway	REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS	KPNA4 TPR KPNA3	1.17e-04	41	33	3	M29574
Pathway	REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES	NFYA NFYC	2.36e-04	10	33	2	M801
Pathway	REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES	NFYA NFYC	3.46e-04	12	33	2	M794
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	KMT2C ARID1A EP400 CLOCK SUPT7L	3.93e-04	272	33	5	M29619
Pathway	PID_MYC_REPRESS_PATHWAY	NFYA NFYC BRCA1	4.22e-04	63	33	3	M254
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	KMT2C BRCA1 ARID1A	4.62e-04	65	33	3	M39682
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	SP3 BRCA1 EP400 TCF7L1 MED12	6.24e-04	301	33	5	MM15983
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	NFYA NFYC	6.25e-04	16	33	2	M27940
Pathway	REACTOME_ISG15_ANTIVIRAL_MECHANISM	KPNA4 TPR KPNA3	6.77e-04	74	33	3	M48006
Pathway	PID_SMAD2_3NUCLEAR_PATHWAY	MED15 SP3 RUNX2	9.13e-04	82	33	3	M2
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	NFYA MED15 NFYC KMT2C PHC3 RUNX2 BRCA1 ARID1A TCF7L1 MED12	9.17e-04	1387	33	10	M734
Pathway	REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	NFYA NFYC	1.80e-03	27	33	2	M796
Pubmed	Human transcription factor protein interaction networks.	NFYA MED15 NFYC SP2 KMT2C PHC3 CEP152 QSER1 RASSF8 SMG7 BRCA1 ARID1A EP400 NIPBL SUPT7L SCAF4	5.64e-12	1429	43	16	35140242
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	CIZ1 KPNA4 MED15 NFYC SP2 KMT2C PHC3 ARID1A EP400 KPNA3	4.71e-11	398	43	10	35016035
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CIZ1 MED15 TPR KMT2C QSER1 SMG7 ARID1A EP400 MED12 SCAF4	1.06e-09	549	43	10	38280479
Pubmed	O-GlcNAc modification of Sp3 and Sp4 transcription factors negatively regulates their transcriptional activities.	SP2 SP3 SP4	1.76e-09	3	43	3	26431879
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	KPNA4 USP34 SP2 PHC3 QSER1 ARID1A EP400 CLOCK	1.92e-09	282	43	8	23667531
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	NFYA CIZ1 NFYC SP2 SP3 SP4 RUNX2 ARID1A CLOCK RFX3 TCF7L1	2.91e-09	808	43	11	20412781
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	MED15 KMT2C SP4 QRICH1 QSER1 RUNX2 BRCA1 ARID1A EP400 NIPBL MED12 SCAF4	6.04e-09	1103	43	12	34189442
Pubmed	Sp2 is the only glutamine-rich specificity protein with minor impact on development and differentiation in myelinating glia.	SP2 SP3 SP4	7.04e-09	4	43	3	27889927
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	CIZ1 TPR PHC3 QSER1 BRCA1 ARID1A EP400 NIPBL SCAF4 SMC6 KPNA3	1.61e-08	954	43	11	36373674
Pubmed	Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.	SP2 SP3 SP4	1.76e-08	5	43	3	10547281
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CIZ1 KPNA4 MED15 KMT2C PHC3 SP3 BRCA1 EP400 NIPBL MED12 SUPT7L SCAF4 KPNA3	1.81e-08	1497	43	13	31527615
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	MED15 PHC3 ARID1A EP400 MED12	2.41e-08	69	43	5	28481362
Pubmed	Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells.	SP2 SP3 SP4	3.51e-08	6	43	3	16201967
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CIZ1 SP2 KMT2C PHC3 QSER1 BRCA1 ARID1A EP400 CLOCK NIPBL SUPT7L SCAF4	3.52e-08	1294	43	12	30804502
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	MED15 QSER1 ARID1A EP400 NIPBL MED12 SUPT7L	3.79e-08	268	43	7	33640491
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	KPNA4 TPR KMT2C SP3 QRICH1 GJD2 SMG7 NIPBL SLC20A1 MED12 SMC6 KPNA3	4.64e-08	1327	43	12	32694731
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	MED15 USP34 QRICH1 BRCA1 ARID1A EP400 MED12 SMC6	7.58e-08	453	43	8	29656893
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	MED15 TPR USP34 KMT2C QRICH1 QSER1 SMG7 ARID1A	8.10e-08	457	43	8	32344865
Pubmed	Interaction network of human early embryonic transcription factors.	MED15 KMT2C QSER1 ARID1A EP400 NIPBL MED12	2.37e-07	351	43	7	38297188
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NFYC TPR USP34 KMT2C PHC3 MFAP2 QSER1 SLC20A1 SMC6 KPNA3	6.25e-07	1084	43	10	11544199
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	KPNA4 QRICH1 QSER1 EP400 RFX3 NIPBL MED12	6.72e-07	410	43	7	26949251
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CIZ1 USP34 EP400P1 SMG7 BRCA1 ARID1A EP400 TCF7L1 SUPT7L KPNA3	8.13e-07	1116	43	10	31753913
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	KMT2C QSER1 BRCA1 ARID1A EP400	1.03e-06	146	43	5	23892456
Pubmed	A census of human transcription factors: function, expression and evolution.	NFYA NFYC SP2 SP3 SP4 RUNX2 CLOCK RFX3 TCF7L1	1.38e-06	908	43	9	19274049
Pubmed	Genetic loss of importin α4 causes abnormal sperm morphology and impacts on male fertility in mouse.	KPNA4 KPNA3	1.49e-06	2	43	2	33058343
Pubmed	Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive Breast Cancer.	KMT2C SLC20A1	1.49e-06	2	43	2	27986439
Pubmed	Cellular Importin-α3 Expression Dynamics in the Lung Regulate Antiviral Response Pathways against Influenza A Virus Infection.	KPNA4 KPNA3	1.49e-06	2	43	2	32320654
Pubmed	Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-κB.	KPNA4 KPNA3	1.49e-06	2	43	2	28179530
Pubmed	Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes.	SP3 SP4	1.49e-06	2	43	2	1454515
Pubmed	Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression.	SP2 SP3	1.49e-06	2	43	2	1341900
Pubmed	Studies on the structure of the mouse CBF-A gene and properties of a truncated CBF-A isoform generated from an alternatively spliced RNA.	NFYA RUNX2	1.49e-06	2	43	2	7509302
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	MED15 KMT2C ARID1A EP400 MED12	2.00e-06	167	43	5	20362541
Pubmed	Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.	SP3 BRCA1 ARID1A CLOCK	2.57e-06	77	43	4	19505873
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	MED15 EP400 MED12	3.06e-06	23	43	3	9225980
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MED15 TPR USP34 QRICH1 QSER1 EP400 NIPBL MED12 SMC6	3.40e-06	1014	43	9	32416067
Pubmed	Mammalian SP/KLF transcription factors: bring in the family.	SP2 SP3 SP4	3.97e-06	25	43	3	15820306
Pubmed	Loss of MED12 activates the TGFβ pathway to promote chemoresistance and replication fork stability in BRCA-deficient cells.	BRCA1 MED12	4.48e-06	3	43	2	34871431
Pubmed	Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox.	NFYA NFYC	4.48e-06	3	43	2	8910521
Pubmed	Nuclear localization signal in a cancer-related transcriptional regulator protein NAC1.	KPNA4 KPNA3	4.48e-06	3	43	2	22665369
Pubmed	Sp proteins and Runx2 mediate regulation of matrix gla protein (MGP) expression by parathyroid hormone.	SP3 RUNX2	4.48e-06	3	43	2	19306294
Pubmed	Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms.	SP3 SP4	4.48e-06	3	43	2	23540600
Pubmed	Nuclear factor Y (NF-Y) and cellular senescence.	NFYA NFYC	4.48e-06	3	43	2	10585259
Pubmed	Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.	SP3 SP4	4.48e-06	3	43	2	26967243
Pubmed	Curcumin decreases specificity protein expression in bladder cancer cells.	SP3 SP4	4.48e-06	3	43	2	18593936
Pubmed	Transcriptional regulation of the mouse gene encoding the alpha-4 subunit of the GABAA receptor.	SP3 SP4	4.48e-06	3	43	2	15265862
Pubmed	Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene.	SP3 SP4	4.48e-06	3	43	2	11532028
Pubmed	Histone-fold domain protein NF-Y promotes chromatin accessibility for cell type-specific master transcription factors.	NFYA NFYC	4.48e-06	3	43	2	25132174
Pubmed	The molecular biology of the CCAAT-binding factor NF-Y.	NFYA NFYC	4.48e-06	3	43	2	10571030
Pubmed	Epigenetic role of CCAAT box-binding transcription factor NF-Y on ID gene family in human embryonic carcinoma cells.	NFYA NFYC	4.48e-06	3	43	2	26509926
Pubmed	Karyopherin α 3 and karyopherin α 4 proteins mediate the nuclear import of methyl-CpG binding protein 2.	KPNA4 KPNA3	4.48e-06	3	43	2	26245896
Pubmed	Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.	SP3 SP4	4.48e-06	3	43	2	21919647
Pubmed	Sequence-specific transcription factor NF-Y displays histone-like DNA binding and H2B-like ubiquitination.	NFYA NFYC	4.48e-06	3	43	2	23332751
Pubmed	Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3.	KPNA4 KPNA3	4.48e-06	3	43	2	10100610
Pubmed	Zinc finger independent genome-wide binding of Sp2 potentiates recruitment of histone-fold protein Nf-y distinguishing it from Sp1 and Sp3.	SP2 SP3	4.48e-06	3	43	2	25793500
Pubmed	Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3.	SP3 SP4	4.48e-06	3	43	2	7559627
Pubmed	Mediator and cohesin connect gene expression and chromatin architecture.	MED15 NIPBL MED12	5.64e-06	28	43	3	20720539
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	TPR USP34 KMT2C ARID1A MED12	7.66e-06	220	43	5	35785414
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NFYA NFYC TPR QRICH1 QSER1 KIF27 EP400 RFX3	8.89e-06	857	43	8	25609649
Pubmed	Cancer gene mutation frequencies for the U.S. population.	KMT2C ARID1A	8.94e-06	4	43	2	34645806
Pubmed	Sp4 is expressed in retinal neurons, activates transcription of photoreceptor-specific genes, and synergizes with Crx.	SP3 SP4	8.94e-06	4	43	2	15781457
Pubmed	Importin α3 regulates chronic pain pathways in peripheral sensory neurons.	KPNA4 KPNA3	8.94e-06	4	43	2	32792398
Pubmed	MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection.	KPNA4 KPNA3	8.94e-06	4	43	2	29370303
Pubmed	Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression.	KPNA4 KPNA3	8.94e-06	4	43	2	19710421
Pubmed	Endoplasmic reticulum stress-induced formation of transcription factor complex ERSF including NF-Y (CBF) and activating transcription factors 6alpha and 6beta that activates the mammalian unfolded protein response.	NFYA NFYC	8.94e-06	4	43	2	11158310
Pubmed	NF-Y binding is required for transactivation of neuronal aromatic L-amino acid decarboxylase gene promoter by the POU-domain protein Brn-2.	NFYA NFYC	8.94e-06	4	43	2	11311976
Pubmed	NF-Y recruits Ash2L to impart H3K4 trimethylation on CCAAT promoters.	NFYA NFYC	8.94e-06	4	43	2	21445285
Pubmed	ZBP-89 and Sp3 down-regulate while NF-Y up-regulates SOX18 promoter activity in HeLa cells.	NFYA SP3	8.94e-06	4	43	2	18496767
Pubmed	Transcriptional modulation of the pre-implantation embryo-specific Rnf35 gene by the Y-box protein NF-Y/CBF.	NFYA NFYC	8.94e-06	4	43	2	15516209
Pubmed	Regulation of expression of the chorionic gonadotropin/luteinizing hormone receptor gene in the human myometrium: involvement of specificity protein-1 (Sp1), Sp3, Sp4, Sp-like proteins, and histone deacetylases.	SP2 SP4	8.94e-06	4	43	2	15788387
Pubmed	Subcellular distribution of importins correlates with germ cell maturation.	KPNA4 KPNA3	8.94e-06	4	43	2	17654710
Pubmed	Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family.	KPNA4 KPNA3	8.94e-06	4	43	2	9395085
Pubmed	Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Sp proteins.	SP3 SP4	8.94e-06	4	43	2	16574784
Pubmed	Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y).	NFYA NFYC	8.94e-06	4	43	2	9388234
Pubmed	NF-Y affects histone acetylation and H2A.Z deposition in cell cycle promoters.	NFYA NFYC	8.94e-06	4	43	2	21304275
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	CIZ1 FSIP2 PHC3 QSER1 BRCA1 NIPBL SMC6	9.00e-06	608	43	7	36089195
Pubmed	A protein interaction landscape of breast cancer.	KPNA4 TPR RUNX2 BRCA1 ARID1A SCAF4 KPNA3	1.18e-05	634	43	7	34591612
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CIZ1 MED15 CEP152 BRCA1 EP400 MED12 SMC6	1.32e-05	645	43	7	25281560
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	KPNA4 PHC3 SP3 SP4 EP400 KPNA3	1.43e-05	430	43	6	35044719
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	KMT2C QSER1 NIPBL KPNA3	1.45e-05	119	43	4	23508102
Pubmed	Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.	SP3 SP4	1.49e-05	5	43	2	20538607
Pubmed	Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function.	NFYA NFYC	1.49e-05	5	43	2	12482752
Pubmed	Bone morphogenetic protein 2 mediates dentin sialophosphoprotein expression and odontoblast differentiation via NF-Y signaling.	NFYA NFYC	1.49e-05	5	43	2	18424784
Pubmed	Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation.	KMT2C BRCA1	1.49e-05	5	43	2	27653681
Pubmed	Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.	NFYA NFYC	1.49e-05	5	43	2	15831478
Pubmed	Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors.	SP3 SP4	1.49e-05	5	43	2	12560508
Pubmed	Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal.	KPNA4 KPNA3	1.49e-05	5	43	2	19961612
Pubmed	Identification of novel homologues of mouse importin alpha, the alpha subunit of the nuclear pore-targeting complex, and their tissue-specific expression.	KPNA4 KPNA3	1.49e-05	5	43	2	9369227
Pubmed	Identification of the G13 (cAMP-response-element-binding protein-related protein) gene product related to activating transcription factor 6 as a transcriptional activator of the mammalian unfolded protein response.	NFYA NFYC	1.49e-05	5	43	2	11256944
Pubmed	Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite.	KPNA4 KPNA3	1.49e-05	5	43	2	17981117
Pubmed	Transcriptional regulation of P450scc gene expression in the embryonic rodent nervous system.	SP2 SP4	2.23e-05	6	43	2	14576192
Pubmed	Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.	KPNA4 KPNA3	2.23e-05	6	43	2	8551560
Pubmed	Differential intranuclear organization of transcription factors Sp1 and Sp3.	SP2 SP3	2.23e-05	6	43	2	15987735
Pubmed	Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.	NFYA NFYC	2.23e-05	6	43	2	12857729
Pubmed	HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.	KPNA4 KPNA3	2.23e-05	6	43	2	7859280
Pubmed	Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.	KPNA4 KPNA3	2.23e-05	6	43	2	8529100
Pubmed	Karyopherin alpha7 (KPNA7), a divergent member of the importin alpha family of nuclear import receptors.	KPNA4 KPNA3	2.23e-05	6	43	2	20701745
Pubmed	Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection.	KPNA4 KPNA3	2.23e-05	6	43	2	9008157
Pubmed	p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y.	NFYA NFYC	2.23e-05	6	43	2	14586402
Pubmed	p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.	KPNA4 KPNA3	2.23e-05	6	43	2	2064827
Pubmed	A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal.	KPNA4 KPNA3	2.23e-05	6	43	2	15037073
Interaction	CRX interactions	MED15 NFYC KMT2C SP3 SP4 QRICH1 QSER1 ARID1A EP400 NIPBL MED12	4.14e-12	254	43	11	int:CRX
Interaction	FHL2 interactions	NFYC SP2 PHC3 SP3 SP4 QRICH1 QSER1 RUNX2 BRCA1 EP400 RFX3	4.81e-10	396	43	11	int:FHL2
Interaction	POLR2H interactions	NFYA NFYC MED12L BDP1 RASSF8 BRCA1 MED12 SCAF4	2.06e-08	223	43	8	int:POLR2H
Interaction	SOX9 interactions	KMT2C PHC3 RUNX2 ARID1A EP400 MED12	5.61e-08	97	43	6	int:SOX9
Interaction	AR interactions	MED15 MED12L TPR USP34 KMT2C QSER1 RUNX2 BRCA1 ARID1A EP400 NIPBL MED12 SUPT7L	8.49e-08	992	43	13	int:AR
Interaction	FEV interactions	SP2 KMT2C PHC3 QSER1 ARID1A EP400 NIPBL	2.25e-07	203	43	7	int:FEV
Interaction	TLE3 interactions	MED15 PHC3 QRICH1 SMG7 ARID1A CLOCK NIPBL SCAF4	1.12e-06	376	43	8	int:TLE3
Interaction	CEBPA interactions	NFYA MED15 KMT2C SP4 QRICH1 QSER1 RUNX2 BRCA1 ARID1A EP400 NIPBL MED12 SCAF4	1.15e-06	1245	43	13	int:CEBPA
Interaction	TERF2IP interactions	CIZ1 KPNA4 PHC3 QSER1 BRCA1 ARID1A EP400 NIPBL SUPT7L	2.00e-06	552	43	9	int:TERF2IP
Interaction	HDAC1 interactions	NFYA KPNA4 NFYC TPR SP3 RUNX2 BRCA1 ARID1A EP400 RFX3 MED12 KPNA3	2.25e-06	1108	43	12	int:HDAC1
Interaction	KLF15 interactions	MED15 NFYC SP2 KMT2C QSER1 EP400 NIPBL	2.46e-06	290	43	7	int:KLF15
Interaction	MED26 interactions	KPNA4 MED15 MED12L MED12 SCAF4	3.15e-06	107	43	5	int:MED26
Interaction	SP7 interactions	KMT2C QSER1 BRCA1 ARID1A EP400 NIPBL SCAF4	3.36e-06	304	43	7	int:SP7
Interaction	MED17 interactions	MED15 MED12L BRCA1 MED12 SUPT7L SCAF4	4.21e-06	202	43	6	int:MED17
Interaction	NUP43 interactions	CIZ1 FSIP2 USP34 PHC3 BRCA1 ARID1A EP400 NIPBL MED12	5.50e-06	625	43	9	int:NUP43
Interaction	SMC5 interactions	CIZ1 TPR PHC3 QSER1 BRCA1 ARID1A EP400 NIPBL SCAF4 SMC6 KPNA3	5.65e-06	1000	43	11	int:SMC5
Interaction	SNRNP40 interactions	CIZ1 PHC3 QRICH1 BRCA1 ARID1A EP400 MED12 SCAF4 KPNA3	6.41e-06	637	43	9	int:SNRNP40
Interaction	NANOG interactions	USP34 KMT2C QSER1 BRCA1 ARID1A EP400 TCF7L1 MED12	6.91e-06	481	43	8	int:NANOG
Interaction	CDK8 interactions	MED15 MED12L BRCA1 NIPBL MED12 SUPT7L	7.24e-06	222	43	6	int:CDK8
Interaction	MKI67 interactions	KPNA4 QRICH1 QSER1 BRCA1 EP400 RFX3 NIPBL MED12 SMC6	7.36e-06	648	43	9	int:MKI67
Interaction	NFIX interactions	KMT2C QRICH1 QSER1 ARID1A EP400 NIPBL	8.23e-06	227	43	6	int:NFIX
Interaction	PAX6 interactions	NFYC KMT2C QRICH1 QSER1 ARID1A EP400 NIPBL	1.13e-05	366	43	7	int:PAX6
Interaction	TP53BP1 interactions	MED15 USP34 BRCA1 ARID1A EP400 MED12 SMC6 KPNA3	1.46e-05	533	43	8	int:TP53BP1
Interaction	CTDSPL2 interactions	KPNA4 MED15 NIPBL KPNA3	1.49e-05	70	43	4	int:CTDSPL2
Interaction	MED13L interactions	MED15 MED12L NIPBL MED12	1.57e-05	71	43	4	int:MED13L
Interaction	RB1 interactions	KPNA4 BDP1 SP3 RUNX2 BRCA1 CLOCK KPNA3	1.82e-05	394	43	7	int:RB1
Interaction	MED23 interactions	MED15 NFYC MED12L EP400 NIPBL MED12	2.02e-05	266	43	6	int:MED23
Interaction	PML interactions	KPNA4 MED15 USP34 SP2 SP3 QRICH1 RUNX2 BRCA1 EP400 SMC6	2.05e-05	933	43	10	int:PML
Interaction	MED21 interactions	MED15 MED12L BRCA1 MED12 SCAF4	2.17e-05	159	43	5	int:MED21
Interaction	KDM1A interactions	TPR USP34 PHC3 CEP152 RASSF8 SMG7 BRCA1 EP400 CLOCK MED12	2.21e-05	941	43	10	int:KDM1A
Interaction	FOXJ2 interactions	NFYC QRICH1 QSER1 RFX3	2.65e-05	81	43	4	int:FOXJ2
Interaction	TNRC6A interactions	KMT2C CEP152 SMG7 BRCA1 ARID1A MED12	2.70e-05	280	43	6	int:TNRC6A
Interaction	SOX2 interactions	KPNA4 USP34 SP2 KMT2C PHC3 QSER1 RUNX2 ARID1A EP400 CLOCK RFX3 NIPBL	2.86e-05	1422	43	12	int:SOX2
Interaction	NUP35 interactions	MED15 USP34 KMT2C QRICH1 QSER1 SMG7 ARID1A	2.91e-05	424	43	7	int:NUP35
Interaction	MED14 interactions	MED15 MED12L MED12 SCAF4 KPNA3	3.08e-05	171	43	5	int:MED14
Interaction	EGR2 interactions	KMT2C QSER1 ARID1A EP400 NIPBL	3.08e-05	171	43	5	int:EGR2
Interaction	MED13 interactions	MED15 MED12L NIPBL MED12	3.36e-05	86	43	4	int:MED13
Interaction	MED12 interactions	MED15 MED12L BRCA1 NIPBL MED12	3.53e-05	176	43	5	int:MED12
Interaction	NFYC interactions	NFYA NFYC SP2 SP4 EP400	3.63e-05	177	43	5	int:NFYC
Interaction	HIF1A interactions	KPNA4 MED15 RUNX2 BRCA1 EP400 MED12 KPNA3	3.74e-05	441	43	7	int:HIF1A
Interaction	MED20 interactions	MED15 MED12L RUNX2 MED12 SCAF4	4.04e-05	181	43	5	int:MED20
Interaction	MED7 interactions	MED15 MED12L EP400 MED12	4.38e-05	92	43	4	int:MED7
Interaction	HIVEP1 interactions	NFYC SP4 QRICH1 SMG7 BRCA1	4.60e-05	186	43	5	int:HIVEP1
Interaction	HNF1B interactions	KMT2C QSER1 ARID1A EP400 NIPBL	5.09e-05	190	43	5	int:HNF1B
Interaction	MYOD1 interactions	KMT2C ARID1A EP400 NIPBL KPNA3	5.61e-05	194	43	5	int:MYOD1
Interaction	KLF5 interactions	KMT2C QSER1 ARID1A EP400 NIPBL	5.75e-05	195	43	5	int:KLF5
Interaction	MED6 interactions	MED15 MED12L MED12 SCAF4	6.31e-05	101	43	4	int:MED6
Interaction	MED10 interactions	MED15 MED12L MED12 SCAF4	6.56e-05	102	43	4	int:MED10
Interaction	MED27 interactions	MED15 MED12L MED12 SCAF4	6.56e-05	102	43	4	int:MED27
Interaction	NFYA interactions	NFYA NFYC QRICH1 BRCA1	7.34e-05	105	43	4	int:NFYA
Interaction	MED1 interactions	MED15 MED12L MED12 SUPT7L SCAF4	7.46e-05	206	43	5	int:MED1
Interaction	MED19 interactions	MED15 MED12L MED12 SCAF4	7.62e-05	106	43	4	int:MED19
Interaction	H3C3 interactions	CIZ1 FSIP2 PHC3 QSER1 BRCA1 NIPBL SMC6	7.74e-05	495	43	7	int:H3C3
Interaction	SP2 interactions	NFYC SP2 QRICH1	7.84e-05	39	43	3	int:SP2
Interaction	MED9 interactions	MED15 MED12L MED12 KPNA3	8.19e-05	108	43	4	int:MED9
Interaction	MRGBP interactions	KPNA4 EP400P1 EP400 KPNA3	8.49e-05	109	43	4	int:MRGBP
Interaction	EN1 interactions	KMT2C QSER1 EP400 NIPBL	8.80e-05	110	43	4	int:EN1
Interaction	PAX8 interactions	KMT2C QSER1 ARID1A NIPBL	9.12e-05	111	43	4	int:PAX8
Interaction	TOP1 interactions	NFYA NFYC TPR BRCA1 ARID1A EP400 NIPBL SCAF4	9.66e-05	696	43	8	int:TOP1
Interaction	KAT5 interactions	KPNA4 TPR BRCA1 EP400 CLOCK KPNA3	1.05e-04	358	43	6	int:KAT5
Interaction	MED28 interactions	MED15 MED12L MED12 SCAF4	1.08e-04	116	43	4	int:MED28
Interaction	TBXT interactions	KMT2C QSER1 ARID1A NIPBL	1.08e-04	116	43	4	int:TBXT
Interaction	SP1 interactions	NFYA NFYC SP2 SP3 SP4 BRCA1	1.17e-04	365	43	6	int:SP1
Interaction	MED16 interactions	MED15 MED12L MED12 SUPT7L	1.23e-04	120	43	4	int:MED16
Interaction	ETS1 interactions	RUNX2 BRCA1 ARID1A EP400	1.27e-04	121	43	4	int:ETS1
Interaction	MED8 interactions	MED15 MED12L MED12 SCAF4	1.27e-04	121	43	4	int:MED8
Interaction	SP4 interactions	NFYC SP3 SP4	1.29e-04	46	43	3	int:SP4
Interaction	MED12L interactions	MED15 MED12L MED12	1.37e-04	47	43	3	int:MED12L
Interaction	SMAD2 interactions	MED15 NFYC KMT2C RUNX2 BRCA1 ARID1A	1.57e-04	385	43	6	int:SMAD2
Interaction	PAX9 interactions	KMT2C QSER1 ARID1A NIPBL	1.68e-04	130	43	4	int:PAX9
Interaction	MED15 interactions	MED15 MED12L RUNX2 MED12	1.73e-04	131	43	4	int:MED15
Interaction	ASF1A interactions	BDP1 QSER1 BRCA1 ARID1A EP400	1.81e-04	249	43	5	int:ASF1A
Interaction	NKX3-1 interactions	SP2 SP3 SP4	1.86e-04	52	43	3	int:NKX3-1
Interaction	TBP interactions	NFYA NFYC BDP1 SP3 SUPT7L	1.95e-04	253	43	5	int:TBP
Interaction	H2BC8 interactions	CIZ1 PHC3 QSER1 BRCA1 EP400 NIPBL KPNA3	1.98e-04	576	43	7	int:H2BC8
Interaction	KAT2B interactions	NFYA NFYC RUNX2 CLOCK SUPT7L	2.06e-04	256	43	5	int:KAT2B
Interaction	POU5F1 interactions	NFYC TPR USP34 ARID1A EP400 TCF7L1 KPNA3	2.15e-04	584	43	7	int:POU5F1
Interaction	SRF interactions	NFYA NFYC SP2 PHC3	2.17e-04	139	43	4	int:SRF
Interaction	HMGA2 interactions	NFYA KPNA4 NFYC SP2	2.23e-04	140	43	4	int:HMGA2
Interaction	ESRRB interactions	MED15 KMT2C ARID1A EP400 MED12	2.30e-04	262	43	5	int:ESRRB
Interaction	POGZ interactions	NFYA NFYC SP3 SP4 QRICH1	2.42e-04	265	43	5	int:POGZ
Interaction	CREBBP interactions	NFYA SP3 RUNX2 SMG7 BRCA1 ARID1A CLOCK	2.52e-04	599	43	7	int:CREBBP
Interaction	EMSY interactions	NFYC PHC3 QSER1 BRCA1	2.55e-04	145	43	4	int:EMSY
Interaction	WWTR1 interactions	QSER1 RUNX2 SMG7 ARID1A EP400 CLOCK	2.57e-04	422	43	6	int:WWTR1
Interaction	NCOA1 interactions	RUNX2 SMG7 BRCA1 ARID1A	2.62e-04	146	43	4	int:NCOA1
Interaction	HNF4A interactions	KMT2C QSER1 ARID1A EP400 NIPBL	2.87e-04	275	43	5	int:HNF4A
Interaction	TFAP4 interactions	SP3 BRCA1 ARID1A CLOCK	3.13e-04	153	43	4	int:TFAP4
Interaction	POLR2K interactions	BDP1 BRCA1 SCAF4 KPNA3	3.29e-04	155	43	4	int:POLR2K
Interaction	FASN interactions	KPNA4 KMT2C GJD2 SMG7 BRCA1 NIPBL SLC20A1 MED12 SMC6	3.37e-04	1062	43	9	int:FASN
Interaction	CUX2 interactions	KPNA4 KPNA3	3.42e-04	13	43	2	int:CUX2
Interaction	RAD52 interactions	NFYC BRCA1 KPNA3	3.44e-04	64	43	3	int:RAD52
Interaction	YAP1 interactions	CIZ1 MED15 TPR KMT2C RASSF8 RUNX2 ARID1A MED12 SCAF4	4.22e-04	1095	43	9	int:YAP1
Interaction	TP73 interactions	MED15 NFYC SP3 BRCA1	4.56e-04	169	43	4	int:TP73
Interaction	MED11 interactions	MED15 MED12L MED12	4.67e-04	71	43	3	int:MED11
Interaction	RPRD1A interactions	BRCA1 CLOCK SCAF4 KPNA3	5.09e-04	174	43	4	int:RPRD1A
Interaction	TLX1 interactions	KMT2C QSER1 ARID1A NIPBL	5.21e-04	175	43	4	int:TLX1
Interaction	RELA interactions	KPNA4 MED15 IRAK1BP1 SP3 BRCA1 KPNA3	5.39e-04	485	43	6	int:RELA
Interaction	POLR1G interactions	CIZ1 KPNA4 PHC3 EP400 NIPBL KPNA3	5.63e-04	489	43	6	int:POLR1G
Interaction	POLR2G interactions	MED15 BRCA1 MED12 SCAF4	5.67e-04	179	43	4	int:POLR2G
Interaction	LHX3 interactions	KMT2C QRICH1 ARID1A NIPBL	6.41e-04	185	43	4	int:LHX3
Cytoband	1q25	TPR SMG7	2.75e-04	26	43	2	1q25
Cytoband	12q24.33	EP400P1 EP400	9.40e-04	48	43	2	12q24.33
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP2 SP3 SP4	3.10e-07	9	29	3	755
GeneFamily	Ataxins\|Trinucleotide repeat containing	MED15 EP400 MED12	8.33e-06	25	29	3	775
GeneFamily	Cyclins\|Mediator complex	MED15 MED12L MED12	1.96e-05	33	29	3	1061
GeneFamily	Armadillo repeat containing\|Importins	KPNA4 KPNA3	3.74e-04	18	29	2	596
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	KPNA4 KPNA3	2.15e-03	43	29	2	409
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	BDP1 EP400	3.25e-03	53	29	2	532
Coexpression	RIZ_ERYTHROID_DIFFERENTIATION	NFYC SP3 ANK1 BRCA1 CLOCK	2.32e-07	82	43	5	M16458
Coexpression	RIZ_ERYTHROID_DIFFERENTIATION	NFYC SP3 ANK1 BRCA1 CLOCK	2.78e-07	85	43	5	MM1106
Coexpression	SENESE_HDAC1_TARGETS_UP	NFYA KPNA4 BDP1 TPR USP34 ABCC9 RASSF8 SMG7	6.18e-07	451	43	8	M14973
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	KPNA4 TPR USP34 KMT2C QSER1 RUNX2 RFX3 NIPBL SMC6	2.09e-06	721	43	9	M10237
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	KPNA4 BDP1 TPR USP34 KMT2C PHC3 SP3 RUNX2 ARID1A EP400 NIPBL SLC20A1	3.26e-06	1492	43	12	M40023
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	MED15 SMG7 ARID1A CLOCK SLC20A1	1.83e-05	199	43	5	M9964
Coexpression	GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP	TPR CLOCK SLC20A1 MED12 SUPT7L	1.87e-05	200	43	5	M5817
Coexpression	BURTON_ADIPOGENESIS_12	SP3 ARID1A NIPBL	1.97e-05	32	43	3	MM668
Coexpression	BURTON_ADIPOGENESIS_12	SP3 ARID1A NIPBL	1.97e-05	32	43	3	M1558
Coexpression	JAK2_DN.V1_DN	PHC3 CEP152 RFX3 SCAF4	9.89e-05	147	43	4	M2872
Coexpression	GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN	NFYA QSER1 RUNX2 ANK1	1.04e-04	149	43	4	M6683
Coexpression	SENESE_HDAC3_TARGETS_UP	NFYA BDP1 TPR USP34 SMG7 RFX3	1.48e-04	495	43	6	M8451
Coexpression	GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	BDP1 TPR NIPBL SLC20A1	1.58e-04	166	43	4	M8129
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	MED12L KMT2C BRCA1 ARID1A	2.15e-04	180	43	4	M8239
Coexpression	GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP	TPR USP34 BRCA1 SUPT7L	2.34e-04	184	43	4	M9988
Coexpression	GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN	SP3 SP4 ARID1A RFX3	2.34e-04	184	43	4	M6593
Coexpression	JOHNSTONE_PARVB_TARGETS_2_DN	NFYA USP34 PHC3 RASSF8 RUNX2	2.42e-04	344	43	5	M2239
Coexpression	GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP	NFYA RUNX2 SLC20A1 SMC6	3.16e-04	199	43	4	M4970
Coexpression	GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN	NFYC TPR SP4 SMG7	3.22e-04	200	43	4	M4979
Coexpression	GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN	KMT2C QSER1 RASSF8 SCAF4	3.22e-04	200	43	4	M8278
Coexpression	GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN	SP4 ARID1A NIPBL SMC6	3.22e-04	200	43	4	M7441
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	BDP1 TPR IRAK1BP1 ABCC9 QSER1 RUNX2 ARID1A NIPBL SLC20A1 SMC6	1.15e-08	432	43	10	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	BDP1 TPR IRAK1BP1 ABCC9 PHC3 RUNX2 ANK1 ARID1A NIPBL	1.47e-05	744	43	9	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1	TPR IRAK1BP1 ABCC9 RUNX2 NIPBL	2.08e-05	166	43	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	BDP1 TPR IRAK1BP1 ABCC9 QSER1 RUNX2 ARID1A NIPBL SLC20A1 SMC6	2.16e-05	989	43	10	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	NFYC TPR PHC3 SP3 QSER1 RUNX2 ARID1A RFX3 NIPBL SLC20A1 SMC6	2.87e-05	1252	43	11	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	NFYC BDP1 TPR SP4 QSER1 BRCA1 ARID1A NIPBL SLC20A1 TCF7L1 SMC6	2.97e-05	1257	43	11	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	TPR SP3 QSER1 BRCA1 ARID1A RFX3 NIPBL SLC20A1 TCF7L1 SMC6	3.91e-05	1060	43	10	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	BDP1 BRCA1 NIPBL SLC20A1 SMC6	4.18e-05	192	43	5	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	NFYC TPR SP2 SP4 BRCA1 ARID1A RFX3 NIPBL SLC20A1 TCF7L1 SMC6	6.53e-05	1370	43	11	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	NFYC BDP1 TPR SP4 QSER1 BRCA1 ARID1A NIPBL SLC20A1 TCF7L1 SMC6	1.15e-04	1459	43	11	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	BDP1 IRAK1BP1 QSER1 ARID1A NIPBL SLC20A1 SMC6	2.47e-04	629	43	7	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	BDP1 TPR ABCC9 ARID1A NIPBL	3.27e-04	298	43	5	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	BDP1 BRCA1 NIPBL SLC20A1 SMC6	3.98e-04	311	43	5	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	TPR SP3 QSER1 BRCA1 ARID1A RFX3 NIPBL SLC20A1 TCF7L1 SMC6	4.20e-04	1414	43	10	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	BDP1 TPR QSER1 SLC20A1	5.39e-04	186	43	4	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	BDP1 SMG7 BRCA1 RFX3 NIPBL SMC6	6.67e-04	532	43	6	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BDP1 TPR USP34 MFAP2 NIPBL SMC6	3.18e-08	194	43	6	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 TPR USP34 KMT2C NIPBL	1.39e-06	200	43	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GJD2 RASSF8 RUNX2 ANK1	2.95e-05	184	43	4	2ba98708dfd7f1b2a661578a334684094ff453ad
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TPR USP34 PHC3 SP3	3.08e-05	186	43	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 KMT2C NIPBL SLC20A1	3.21e-05	188	43	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MED12L CEP152 ANK1 BRCA1	3.70e-05	195	43	4	c96755d2eb98112b703b5dbee9c88730ace7dcbf
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 ABCC9 PHC3 SP4	3.93e-05	198	43	4	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 ABCC9 PHC3 SP4	3.93e-05	198	43	4	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	USP34 ABCC9 PHC3 SP4	3.93e-05	198	43	4	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TPR ABCC9 NIPBL SMC6	4.00e-05	199	43	4	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	TPR ABCC9 NIPBL SMC6	4.00e-05	199	43	4	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
Computational	Neighborhood of ZNF198	NFYA QSER1 ARID1A KPNA3	2.23e-04	117	28	4	GCM_ZNF198
Computational	Neighborhood of DFFA	NFYA CIZ1 ARID1A KPNA3	3.24e-04	129	28	4	GCM_DFFA
Computational	Neighborhood of REV3L	TPR BRCA1 EP400	4.44e-04	58	28	3	MORF_REV3L
Drug	SP 0	SP2 SP3 SP4	7.46e-07	10	43	3	CID002742752
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; HL60; HG-U133A	SP2 SP3 CEP152 BRCA1 EP400 NIPBL	1.61e-06	193	43	6	1982_DN
Drug	2-pyridinecarboxaldehyde N-oxide	SP2 SP3	3.48e-06	2	43	2	CID000556031
Drug	6-hydroxyuridine	SP2 SP3	1.04e-05	3	43	2	CID000189012
Drug	AC1MJ1BZ	SP2 SP3	1.04e-05	3	43	2	CID003083813
Drug	ADP-ribosylarginine	SP2 SP3 SP4	1.40e-05	25	43	3	CID000126311
Drug	AC1N3C6T	SP2 SP3	2.09e-05	4	43	2	CID004110181
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	NFYA TPR PHC3 RASSF8 SMG7	2.65e-05	187	43	5	4323_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	NFYA MED15 TPR CLOCK NIPBL	2.86e-05	190	43	5	2619_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	NFYA TPR SMG7 BRCA1 SCAF4	2.93e-05	191	43	5	4811_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	NFYA NFYC QSER1 RASSF8 SMG7	3.00e-05	192	43	5	5206_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	TPR PHC3 SP4 RASSF8 SMG7	3.16e-05	194	43	5	4281_DN
Drug	Morantel tartrate [26155-31-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	NFYA PHC3 CEP152 BRCA1 SUPT7L	3.16e-05	194	43	5	1676_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	TPR USP34 SMG7 ARID1A SCAF4	3.16e-05	194	43	5	1632_UP
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	SMG7 EP400 NIPBL SUPT7L SCAF4	3.16e-05	194	43	5	4662_DN
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A	USP34 PHC3 SMG7 ARID1A EP400	3.24e-05	195	43	5	1296_DN
Drug	Tomatidine [77-59-8]; Down 200; 9.6uM; HL60; HG-U133A	CIZ1 USP34 CEP152 MED12 SCAF4	3.24e-05	195	43	5	1754_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	NFYA ARID1A EP400 MED12 SUPT7L	3.32e-05	196	43	5	1628_DN
Drug	Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A	TPR USP34 PHC3 ARID1A SCAF4	3.40e-05	197	43	5	2812_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	TPR USP34 QSER1 ARID1A SCAF4	3.40e-05	197	43	5	3748_DN
Drug	Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A	NFYA CIZ1 BRCA1 SUPT7L SCAF4	3.40e-05	197	43	5	6232_DN
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	NFYA PHC3 CEP152 SMG7 BRCA1	3.40e-05	197	43	5	2643_DN
Drug	HYCRON linker	KPNA4 KPNA3	3.47e-05	5	43	2	CID011069636
Drug	poly(tetramethylene adipate	SP3 SP4	3.47e-05	5	43	2	CID000032794
Drug	from Dendrobium nobile	SP2 SP3	3.47e-05	5	43	2	CID000355017
Drug	CNI-H0294	KPNA4 KPNA3	3.47e-05	5	43	2	CID000073088
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; HL60; HG-U133A	NFYA CIZ1 SMG7 NIPBL MED12	3.48e-05	198	43	5	2020_DN
Drug	Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; PC3; HT_HG-U133A	MED15 USP34 BRCA1 EP400 SUPT7L	3.48e-05	198	43	5	7270_DN
Drug	Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A	NFYA MED15 TPR USP34 SMG7	3.48e-05	198	43	5	6560_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A	NFYA USP34 NIPBL MED12 SCAF4	3.48e-05	198	43	5	2362_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A	SP2 SMG7 NIPBL MED12 SUPT7L	3.48e-05	198	43	5	6332_DN
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; HL60; HG-U133A	NFYA KPNA4 NFYC USP34 SMG7	3.56e-05	199	43	5	1779_DN
Drug	Spiperone [749-02-0]; Down 200; 10.2uM; HL60; HG-U133A	NFYA CIZ1 NFYC MED12 SCAF4	3.56e-05	199	43	5	1559_DN
Drug	Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NFYA MED15 NFYC NIPBL SCAF4	3.56e-05	199	43	5	6221_DN
Drug	Esculetin [305-01-1]; Down 200; 22.4uM; MCF7; HT_HG-U133A	NFYA KPNA4 MED15 SMG7 BRCA1	3.56e-05	199	43	5	6499_DN
Drug	Eledoisinum	SP2 SP3 SP4	3.60e-05	34	43	3	CID000006242
Drug	Physalemin	SP2 SP3 SP4	3.94e-05	35	43	3	CID000017268
Drug	shikimic acid-3-phosphate	SP2 SP3	5.20e-05	6	43	2	CID000001095
Drug	AC1LA3FM	KPNA4 KPNA3	5.20e-05	6	43	2	CID000480797
Drug	2,5-dimethylthiophene	SP2 SP3	5.20e-05	6	43	2	CID000012514
Drug	dmDBP	KPNA4 KPNA3	5.20e-05	6	43	2	CID005316801
Drug	6-fluoranyl-7H-purine	SP2 SP3	7.27e-05	7	43	2	CID005462117
Drug	isobenzofuran	SP2 SP3	7.27e-05	7	43	2	CID011378474
Drug	3-(2-carboxyindol-3-yl)propionic acid	SP2 SP3 SP4	7.35e-05	43	43	3	CID000169313
Drug	5,5'-dimethyl-2,2'-bipyridine	SP2 SP3	9.69e-05	8	43	2	CID000015664
Drug	Hcda	KPNA4 KPNA3	9.69e-05	8	43	2	CID005312573
Drug	germyl	SP2 SP3	9.69e-05	8	43	2	CID005460457
Drug	ADMCs	RUNX2 BRCA1	9.69e-05	8	43	2	CID000077646
Drug	diazinane	SP2 SP3	9.69e-05	8	43	2	CID000136334
Drug	penconazole	TPR TCF7L1	1.24e-04	9	43	2	ctd:C087058
Drug	Tat11	KPNA4 KPNA3	1.24e-04	9	43	2	CID000480142
Drug	D-IBS	SP2 SP3	1.55e-04	10	43	2	CID000007228
Drug	AC1NE2UB	KPNA4 TPR KPNA3	1.62e-04	56	43	3	CID004635684
Drug	boron nitride	SP2 SP3	2.27e-04	12	43	2	CID000066227
Drug	AC1LAPJB	SP2 SP3	2.27e-04	12	43	2	CID000517869
Drug	NSC-350602	SP2 SP3	2.68e-04	13	43	2	CID006917838
Drug	AC1NSKAN	SP2 SP3	3.13e-04	14	43	2	CID005311244
Drug	A-E-C	MFAP2 ARID1A SCAF4	3.14e-04	70	43	3	CID006438040
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NFYC QSER1 ARID1A CLOCK	3.15e-04	173	43	4	2881_DN
Drug	Thimerosal	FSIP2 BDP1 TPR USP34 SP4 RASSF8 EP400 NIPBL TCF7L1	3.36e-04	1199	43	9	ctd:D013849
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NFYC QRICH1 ARID1A CLOCK	3.51e-04	178	43	4	992_DN
Drug	Phe-gly	KPNA4 SP3 KPNA3	3.56e-04	73	43	3	CID000098207
Drug	AC1L1B35	SP2 SP3 SP4	3.70e-04	74	43	3	CID000001263
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NFYA QRICH1 ARID1A NIPBL	3.82e-04	182	43	4	3887_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NFYC PHC3 CEP152 ARID1A	3.90e-04	183	43	4	3510_DN
Drug	Isoconazole [27523-40-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A	NFYA PHC3 GJD2 ARID1A	4.23e-04	187	43	4	7211_UP
Drug	Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A	PHC3 CEP152 EP400 SCAF4	4.59e-04	191	43	4	4981_DN
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A	CIZ1 MED15 USP34 BRCA1	4.59e-04	191	43	4	5351_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	TPR USP34 SP4 SMG7	4.59e-04	191	43	4	4283_DN
Drug	Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NFYA BRCA1 ARID1A SCAF4	4.68e-04	192	43	4	6207_DN
Drug	Piperine [94-62-2]; Down 200; 14uM; MCF7; HT_HG-U133A	KPNA4 BRCA1 NIPBL SCAF4	4.68e-04	192	43	4	4830_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	NFYA TPR RASSF8 SMG7	4.68e-04	192	43	4	6435_DN
Drug	Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A	NFYA ARID1A EP400 SCAF4	4.77e-04	193	43	4	5839_DN
Drug	Hycanthone [3105-97-3]; Down 200; 11.2uM; PC3; HT_HG-U133A	USP34 PHC3 ARID1A SUPT7L	4.77e-04	193	43	4	4630_DN
Drug	Fenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; PC3; HT_HG-U133A	CIZ1 TPR USP34 NIPBL	4.77e-04	193	43	4	6331_DN
Drug	Spironolactone [52-01-7]; Down 200; 9.6uM; HL60; HG-U133A	NFYA BRCA1 CLOCK NIPBL	4.77e-04	193	43	4	1380_DN
Drug	Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A	CEP152 RASSF8 MED12 SCAF4	4.77e-04	193	43	4	5351_UP
Drug	Glibenclamide [10238-21-8]; Down 200; 8uM; HL60; HG-U133A	CIZ1 EP400 NIPBL MED12	4.77e-04	193	43	4	1546_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; HL60; HG-U133A	CIZ1 MED15 EP400 MED12	4.86e-04	194	43	4	1759_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	MED15 ARID1A EP400 MED12	4.86e-04	194	43	4	1060_UP
Drug	Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; HL60; HG-U133A	CIZ1 SMG7 EP400 NIPBL	4.86e-04	194	43	4	2042_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A	NFYA CIZ1 ARID1A MED12	4.86e-04	194	43	4	1712_DN
Drug	Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NFYA CEP152 NIPBL SCAF4	4.86e-04	194	43	4	3274_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; HL60; HT_HG-U133A	CIZ1 ARID1A CLOCK NIPBL	4.96e-04	195	43	4	2942_UP
Drug	STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A	MED15 CEP152 SMG7 BRCA1	4.96e-04	195	43	4	6561_UP
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; HL60; HT_HG-U133A	NFYA CIZ1 KPNA4 PHC3	4.96e-04	195	43	4	1836_DN
Drug	Tamoxifen citrate [54965-24-1]; Down 200; 7uM; PC3; HT_HG-U133A	NFYA KPNA4 NIPBL SUPT7L	4.96e-04	195	43	4	2050_DN
Drug	Dimaprit dihydrochloride [23256-33-9]; Down 200; 17uM; MCF7; HT_HG-U133A	RASSF8 BRCA1 SUPT7L SCAF4	4.96e-04	195	43	4	7480_DN
Drug	Clopamide [636-54-4]; Down 200; 11.6uM; HL60; HG-U133A	NFYA CIZ1 ARID1A NIPBL	4.96e-04	195	43	4	1605_DN
Drug	Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	PHC3 SMG7 SUPT7L SCAF4	4.96e-04	195	43	4	6795_DN
Drug	Riboflavine [83-88-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A	PHC3 GJD2 ANK1 SUPT7L	4.96e-04	195	43	4	6822_UP
Drug	STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A	NFYC USP34 SMG7 SCAF4	4.96e-04	195	43	4	6906_DN
Drug	Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	TPR BRCA1 TCF7L1 MED12	5.05e-04	196	43	4	7124_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; HL60; HG-U133A	CIZ1 NFYC USP34 MED12	5.05e-04	196	43	4	1567_DN
Drug	quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A	MED15 SMG7 NIPBL MED12	5.05e-04	196	43	4	283_UP
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; HL60; HT_HG-U133A	NFYA TPR PHC3 NIPBL	5.05e-04	196	43	4	2951_DN
Drug	Piretanide [55837-27-9]; Up 200; 11uM; PC3; HT_HG-U133A	CIZ1 QSER1 SMG7 SUPT7L	5.05e-04	196	43	4	4490_UP
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	NFYA NFYC SMG7 SCAF4	5.05e-04	196	43	4	7175_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	MED15 SP2 SUPT7L SCAF4	5.05e-04	196	43	4	2751_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; PC3; HT_HG-U133A	NFYA TPR RASSF8 SMG7	5.05e-04	196	43	4	5806_DN
Disease	Klatskin's tumor (is_implicated_in)	KMT2C ARID1A	1.97e-05	5	42	2	DOID:4927 (is_implicated_in)
Disease	lung non-small cell carcinoma (is_implicated_in)	KMT2C RUNX2 BRCA1 ARID1A	4.59e-05	139	42	4	DOID:3908 (is_implicated_in)
Disease	Malignant neoplasm of breast	NFYC ANK1 BRCA1 ARID1A NIPBL TCF7L1 MED12 SMC6	1.18e-04	1074	42	8	C0006142
Disease	stomach cancer (is_implicated_in)	KMT2C BRCA1 ARID1A	1.49e-04	72	42	3	DOID:10534 (is_implicated_in)
Disease	prostate carcinoma	KPNA4 PHC3 SP3 CEP152 QSER1 RFX3 SLC20A1	2.40e-04	891	42	7	EFO_0001663
Disease	Adenoid Cystic Carcinoma	KMT2C BRCA1 ARID1A	3.94e-04	100	42	3	C0010606
Disease	Intrahepatic Cholangiocarcinoma	KMT2C ARID1A	5.35e-04	24	42	2	C0345905
Disease	stomach carcinoma (is_marker_for)	KMT2C BRCA1	5.35e-04	24	42	2	DOID:5517 (is_marker_for)
Disease	Extrahepatic Cholangiocarcinoma	KMT2C ARID1A	5.35e-04	24	42	2	C3805278
Disease	cancer (implicated_via_orthology)	NFYA PHC3 ARID1A NIPBL	5.68e-04	268	42	4	DOID:162 (implicated_via_orthology)
Disease	Cholangiocarcinoma	KMT2C ARID1A	6.29e-04	26	42	2	C0206698
Disease	Bone Diseases, Developmental	ANK1 NIPBL	6.79e-04	27	42	2	C0005941
Disease	Sezary Syndrome	KMT2C ARID1A	6.79e-04	27	42	2	C0036920
Disease	Thyroid Gland Follicular Adenoma	TPR TCF7L1	1.14e-03	35	42	2	C0151468
Disease	colon cancer (is_implicated_in)	BRCA1 ARID1A	1.21e-03	36	42	2	DOID:219 (is_implicated_in)
Disease	Thyroid Neoplasm	TPR TCF7L1	1.28e-03	37	42	2	C0040136

Protein segments in the cluster

Peptide	Gene	Start	Entry
QQQQTTTTSQVQVPQ	EP400	2781	Q96L91
VVSVGTNNVNTFQQE	BDP1	1546	A6H8Y1
GSVQEVAQLQFQLQQ	CEP152	441	O94986
QNAIVNGVLQNTENT	GJD2	146	Q9UKL4
NTFTQVVQGNEFQNI	ANK1	1791	P16157
CQVQRNETQTSGNQI	CDKL4	326	Q5MAI5
IVQRVNETQNGTNNT	ABCC9	321	O60706
QVNLQQFIQQTGTKV	RASSF8	346	Q8NHQ8
TTSVQPQTQQEQQIQ	QRICH1	81	Q2TAL8
QVQVQVQVQQSPQQV	QRICH1	101	Q2TAL8
VQVQQSPQQVSAQLS	QRICH1	106	Q2TAL8
QQQQQLQVTCSAQTV	QRICH1	436	Q2TAL8
VGSVTQLNQQIGQVN	QSER1	636	Q2KHR3
QPQSQQSQQTAYSQQ	ARID1A	581	O14497
SNITAGNQQQVQAVI	KPNA3	351	O00505
VKNEQQQQQQQQFGS	KMT2C	1776	Q8NEZ4
QVLQQQNIQQGSINS	KMT2C	3481	Q8NEZ4
TQSLQQQGVQAENIT	IRAK1BP1	96	Q5VVH5
GLQQTQQQQQTAALV	MED12L	2106	Q86YW9
VNNVVNEFNNAQVTV	FSIP2	4011	Q5CZC0
QSQQAGVSQTTQINR	KIF27	371	Q86VH2
SVVQNQQQISQQGPI	NIPBL	451	Q6KC79
PQVQQQQTAVQTAQA	MED15	361	Q96RN5
QISSIIQGQLVQQQQ	EP400P1	256	Q6ZTU2
GLQQTQQQQQTAALV	MED12	2141	Q93074
QQQIQPITLQNSTQD	PHC3	331	Q8NDX5
QVQGQQQGQQTTSST	NFYC	156	Q13952
QVVQGQIQTLATNAQ	NFYC	261	Q13952
ITQTEVQQGQQQFSQ	NFYC	296	Q13952
TNQTEQNGQVMNITN	BRCA1	536	P38398
TQGQQLQQILQTFQQ	SCAF4	196	O95104
NGNLVQFSQAVSNQI	SLC20A1	356	Q8WUM9
QFQFQSQQQVQQEVI	MFAP2	61	P55001
STEQIVVQAGQIQQQ	NFYA	11	P23511
VVQAGQIQQQQQGGV	NFYA	16	P23511
QIQQQQQGGVTAVQL	NFYA	21	P23511
QIQIQGGQAVQVQGQ	NFYA	111	P23511
QVQGQQGQTQQIIIQ	NFYA	121	P23511
QGQTQQIIIQQPQTA	NFYA	126	P23511
VTAGQTQTQQQIAVQ	NFYA	141	P23511
TQTQQQIAVQGQQVA	NFYA	146	P23511
FNTTGTQVQNITVTQ	MUC17	4296	Q685J3
DVSPVVAAQQQQQQQ	RUNX2	41	Q13950
AQDQSNSLQQVQIVG	SP4	386	Q02446
QLQSGQTIQTIQQQP	SP4	426	Q02446
QQQGQDGVKVQQATI	SP4	561	Q02446
VQQVPVQQQVQQVQT	RFX3	31	P48380
TSQLQVQALTQQQQS	SMG7	756	Q92540
ATAQAQNQQQTEGVK	SUPT7L	81	O94864
LSVTQQQQQQSSQEQ	CLOCK	751	O15516
QQQQQSSQEQQLTSV	CLOCK	756	O15516
QVQTQTYPQVHTQAQ	CIZ1	426	Q9ULV3
LSQTQSQQQVQEAEG	TCF7L1	431	Q9HCS4
VQQQTQATAFVQPTQ	TPR	1766	P12270
SNSQTIQVQPNLTNQ	SP2	141	Q02086
VTITNTGGQQQLTVQ	SP2	451	Q02086
QESQQPTSQAQIVQG	SP3	401	Q02447
QNQENSVNQEIEQFQ	SMC6	421	Q96SB8
EQINQQAQLQEFGQS	USP34	1251	Q70CQ2
SNITAGNQQQVQAVI	KPNA4	351	O00629